Logo image of ETAO

ETAO INTERNATIONAL CO LTD (ETAO) Stock Fundamental Analysis

NASDAQ:ETAO - KYG313631155 - Common Stock

1.91 USD
-0.89 (-31.79%)
Last: 5/8/2024, 8:00:01 PM
1.25 USD
-0.66 (-34.55%)
After Hours: 5/8/2024, 8:00:01 PM
Fundamental Rating

1

Overall ETAO gets a fundamental rating of 1 out of 10. We evaluated ETAO against 104 industry peers in the Health Care Providers & Services industry. ETAO may be in some trouble as it scores bad on both profitability and health. ETAO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ETAO has reported negative net income.
ETAO had a positive operating cash flow in the past year.
ETAO Yearly Net Income VS EBIT VS OCF VS FCFETAO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 -200M -400M -600M -800M

1.2 Ratios

Looking at the Return On Assets, with a value of -1692.57%, ETAO is doing worse than 98.29% of the companies in the same industry.
Industry RankSector Rank
ROA -1692.57%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ETAO Yearly ROA, ROE, ROICETAO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 2K -2K 4K

1.3 Margins

ETAO has a Gross Margin of 32.72%. This is comparable to the rest of the industry: ETAO outperforms 57.27% of its industry peers.
ETAO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ETAO Yearly Profit, Operating, Gross MarginsETAO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 0 -500 -1K -1.5K

More info and screens

2

2. Health

2.1 Basic Checks

ETAO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ETAO has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, ETAO has a worse debt to assets ratio.
ETAO Yearly Shares OutstandingETAO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 20M 40M 60M 80M 100M
ETAO Yearly Total Debt VS Total AssetsETAO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -68.91, we must say that ETAO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -68.91, ETAO is doing worse than 91.45% of the companies in the same industry.
The Debt to FCF ratio of ETAO is 0.97, which is an excellent value as it means it would take ETAO, only 0.97 years of fcf income to pay off all of its debts.
ETAO has a Debt to FCF ratio of 0.97. This is amongst the best in the industry. ETAO outperforms 90.60% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0.97
Altman-Z -68.91
ROIC/WACCN/A
WACC8.55%
ETAO Yearly LT Debt VS Equity VS FCFETAO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 20M 40M

2.3 Liquidity

ETAO has a Current Ratio of 0.77. This is a bad value and indicates that ETAO is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.77, ETAO is not doing good in the industry: 81.20% of the companies in the same industry are doing better.
ETAO has a Quick Ratio of 0.77. This is a bad value and indicates that ETAO is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ETAO (0.71) is worse than 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.71
ETAO Yearly Current Assets VS Current LiabilitesETAO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 10M 20M 30M 40M 50M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ETAO have decreased strongly by -4967.76% in the last year.
EPS 1Y (TTM)-4967.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5999.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ETAO Yearly Revenue VS EstimatesETAO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 10M 20M 30M 40M 50M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ETAO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ETAO Price Earnings VS Forward Price EarningsETAO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ETAO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ETAO is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.96
EV/EBITDA N/A
ETAO Per share dataETAO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ETAO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ETAO INTERNATIONAL CO LTD

NASDAQ:ETAO (5/8/2024, 8:00:01 PM)

After market: 1.25 -0.66 (-34.55%)

1.91

-0.89 (-31.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.2%
Inst Owner Change-75.29%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.78M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF 0.96
P/OCF 0.9
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.99
FCFY104.2%
OCF(TTM)2.11
OCFY110.68%
SpS11.34
BVpS-3.05
TBVpS-3.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1692.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.72%
FCFM 17.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0.97
Debt/EBITDA N/A
Cap/Depr 32.48%
Cap/Sales 1.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.71
Altman-Z -68.91
F-Score4
WACC8.55%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4967.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5999.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-220440%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4139%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4390.26%
OCF growth 3YN/A
OCF growth 5YN/A